Universities, institutions and companies have defined the most sought-after profile of a rapidly growing sector in 7 points
July 14, 2022 - Under the patronage of An industry, yesterdayUniversità Campus Bio-Medico di Roma organized the conference "Medtech, present future, universities and companies design the future" to discuss with companies on the characteristics of the professional in this strategic sector for the European system. Guests of the event Silvio Brusaferro, President of the Higher Institute of Health, Maria Chiara Carriage, President of the National Research Council, Massimiliano Boggetto, President of the National Alisei Life Sciences Cluster, Massimo Scaccabarozzi, Past president of Farmindustria and representatives of the major companies in the sector. On this occasion, the launch of two new degree courses was announced UCBM delivered entirely in English: Medicine and Surgery Medtech and Biomedical Engineering.
Since the first years of life, the University has focused on interaction and synergistic collaboration between its faculties of Medicine and Surgery and Engineering and today it is a protagonist among Italian universities in research in Medtech sectors such as the development of biomedical devices, imaging biomedical, biomechanics, robotics and assisted surgery, tissue engineering, personalized medicine, human-machine interfaces, rehabilitation and in closely related high-tech areas such as IoT applications, machine learning, big data and cybersecurity. The medtech sector represents the future of healthcare: stimulated by the pandemic, it also grew in 2020 and has development prospects across the planet. In Italy, Medtech generates a market worth 16,2 billion euros divided among 4.546 companies that employ 112.534 employees (Source: Confindustria Medical Devices 2022). The growth rate of turnover (2021 on 2020) reached +6,4 percent against a worldwide growth of 5,6 percent. Investments are growing year on year, with a +9,6 percent in 2021 and further growth prospects in the coming years. In Europe, Italy is sixth exporter, and 13th worldwide in the Medtech sector (source Mediobanca 2022). And it is first in the European Union for the production of drugs (source Efpia 2022).
The doctor of the future will be transversal and in possession of biomedical engineering skills, able to move in the ecosystem of tomorrow's Health Service. Seven characteristics emerged from the conference that the doctor of tomorrow must have in order to operate in hospitals, biomedical and pharmaceutical companies and in research centres:
- HYBRIDIZATION OF KNOWLEDGE, for the health and well-being of the patient;
- OPEN MINDED, to contribute to the technological solutions of tomorrow;
- TRAVERSALITY, for overcoming traditional professional boundaries;
- FLEXIBILITYability to operate in hospital and medtech companies;
- 100% MEDICAL, able to follow the patient on a clinical and human level;
- 100% ENGINEERING TRAINING, to better manage diagnosis and therapies with machinery;
- ABILITY TO HANDLE ETHICAL ISSUES of the patient resulting from the presence of modern technologies.
The day of work was attended by the President UCBM Carlo Tosti, Rector Raffaele Calabrò andCEO and General Manager Andrea Rossi. Among the representatives of the major companies present were Maurizio Tarquini, director of Unindustria; Luigi Ambrosini, DG Abbott; Michele Perrino, president and CEO Medtronic Italia; Filippo Piazza, investment associate Angelini Hive; Stefano Collatina, Country Lead, Italy and integrated Care Solution Head, Baxter South Europe; Patrizia Palazzi, Strategic Sales Expert Siemens Healthcare.
"Today we are faced with the rapid development of personalized medicine: the doctor, the research system and the organization of the healthcare system must deal with technological capabilities that have an ever-increasing role – he said Raffaele Calabrò, Rector ofUniversità Campus Bio-Medico di Roma – Today in medicine we no longer speak generically of "pathologies" but we have the opportunity to understand the problems of the individual patient, and technology becomes fundamental in this. The doctor of tomorrow must be trained to work with new technologies: the pandemic has accelerated this trend: a university like the Campus Bio-Medico in Rome proposes itself as one of the places in which to bring together doctors and companies to create research and innovation for the patient and for the progress of the health system. Our degree courses aim to train the doctor of the future".
